Atlas Trials

REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification

Clinical trial NCT01252953 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01252953
Sponsor
University of Oxford
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Atherosclerotic Cardiovascular Disease
Start date
2011-06-01
Primary completion
2017-01-31
Enrollment
30449

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.